** Shares of medical device maker Kestra Medical Technologies KMTS.O slide ~10.6% to $24.12
** KMTS announces public offering of 5.5 million shares
** BofA Securities, Piper Sandler, J.P. Morgan, Goldman Sachs and Wells Fargo Securities are acting as bookrunners for offering
** Capital raise comes just months after KMTS went public in New York following an upsized $202 million IPO
** Meanwhile, KMTS expects Q2 2026 revenue between $22.2 million and $22.6 million, compared with $14.7 million a year earlier
** Loss from operations expected between $31.6 million and $32 million, compared with $19.1 million a year earlier
** KMTS had ~51.3 million outstanding shares as of July 31, per offering prospectus
** As of last close, KMTS stock up 58.7% since debut in March
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com))
Comments